By expressing neuron-enriched mitochondrial proteins at an early stage, researchers achieved a four times higher conversion rate and increased the speed of reprogramming. This breakthrough may lead to developing reliable regenerative medicine therapies for brain diseases and injuries.
Researchers developed a novel deep learning method that requires less annotated image data to screen for diabetic retinopathy, achieving the same diagnostic performance as human experts. The method enables clinics to automate screenings and reduce referrals to specialized eye care centers.
Researchers at Helmholtz Munich have found a promising therapeutic approach against COPD by blocking lung epithelial cell death and triggering tissue regeneration. The novel treatment targets the lymphotoxin beta receptor signaling pathway, leading to improved lung function and reduced comorbidities.
A recent study by Helmholtz Munich researchers found that a diverse environmental microbiome, particularly in farm children, can protect against childhood asthma. The gut microbiome plays a crucial role in this protective effect, with certain bacteria producing short-chain fatty acids that may contribute to asthma protection.
A novel approach to measuring antibodies against SARS-CoV-2 has been developed, revealing a discrepancy between reported virus-positive cases and actual antibody prevalence. The study found that over 47% of antibody-positive children were asymptomatic, with significant geographic differences in antibody frequency across Bavaria.
Scientists at Helmholtz Zentrum München and TUM developed the world's smallest ultrasound detector, leveraging silicon photonics technology to achieve super-resolution imaging. This innovation enables high-sensitivity detection in smaller sizes than previously possible, opening up new avenues for sensing and imaging applications.
Researchers developed scVelo to estimate RNA velocity with an AI-based model, allowing them to study dynamic populations and understand cellular development and gene activity. This enables better understanding of disease progression and cell signaling, paving the way for personalized treatments.
Researchers have decoded the European maize genome, revealing significant differences in genetic content and genome structure compared to North American lines. These findings suggest that heterosis, a phenomenon increasing crop yields, may be influenced by variations in knob regions and gene regulation.
Researchers discover a way to 'tune down' heterochromatin in early embryos, improving artificial cell reprogramming efficiency. This knowledge can lead to the efficient generation of high-quality stem cells for regenerative medicine approaches.
Researchers at Helmholtz Munich identified hundreds of new information exchange points between plant proteins, revealing that most proteins function in multiple signaling pathways. This discovery may lead to new strategies for biotechnological development or breeding of plants to address climate change challenges.
The COVID-19 crisis has already changed the research community, enabling international collaboration and accelerated data sharing. Biomedical researchers now advocate for smart, lasting investments in global health to address chronic diseases like diabetes and cancer.
Researchers identified IL-8 and IL-33 as key biomarkers for predicting pollen-specific nasal symptoms. These biomarkers also enable the prediction of symptom severity before the start of the pollen season.
Researchers developed an improved pluripotent stem cell differentiation protocol to generate beta cells in vitro, leading to more mature and functional beta cells. The use of CD177 as a quality control marker increases the efficiency and homogeneity of beta cell generation.
Researchers have discovered a new drug combination that can restore beta cell function in an animal model, showing promise for diabetes remission. The treatment, which combines GLP-1/estrogen with insulin, was found to be more effective than single-treatments and increase pancreatic insulin content and beta cell numbers.
Researchers made intact human organs transparent using microscopic imaging, revealing complex structures at the cellular level. The technology, SHANEL, enables detailed analysis of large-scale human tissues and organs, accelerating the development of functional artificial organs.
Researchers defined the proteome of neural stem cell niches and compared it to other brain regions to identify key regulators for neurogenesis. The findings suggest that the unique niche environment allows neurogenesis in the adult mammalian brain, and may contribute to the stiffness of neural stem cell niches.
Researchers at Helmholtz Zentrum München developed a novel therapeutic approach to cure chronic hepatitis B infection. By knocking down the expression of the virus' proteins, they enabled successful vaccination with TherVacB, a novel therapeutic vaccine. The therapy aims to cure existing chronic diseases by activating immune cells.
Scientists identified 3 metabolites that can re-program pluripotent cells into totipotent-like cells, opening up possibilities for studying early developmental events and cell replacement therapies.
Researchers at Helmholtz Munich have created a technique called Mid-infraRed Optoacoustic Microscopy (MiROM) that provides real-time images of biomolecules in living cells without the need for labels or contrast agents. This method offers novel insights into metabolic processes and can be used to study the effects of different diets on...
Researchers developed DeepMACT, a novel algorithm that can detect and analyze cancer metastases more than 300 times faster than human experts. The algorithm provides insights into the unique metastatic profiles of different tumor models, enabling tailored drug targeting for various cancers.
Researchers found that fascia tissue is the origin of scars and contains specialized fibroblasts that pre-assemble to heal wounds. This discovery challenges traditional views of wound healing and opens up new biological concepts for scar-related diseases, potentially leading to novel therapeutic approaches.
A new AI-driven approach can accurately classify single blood cells, improving leukemia diagnostics and reducing variability. The method, trained on over 20,000 images, was compared to human expert accuracy, showing comparable performance in identifying diagnostic blast cells.
A high-caloric diet alters the time-of-day dependent metabolic cycle in mice, suggesting lean and obese patients may respond differently to steroid therapy. The study also highlights the biological function of daily hormone secretion cycles and their impact on sugar and fat storage or release by the liver.
Researchers have developed a novel method to precisely detect and characterize genes in individual cells, enabling selective enrichment of selected molecules. This approach, called BART-Seq, addresses the challenge of detecting low-abundance gene transcripts and has potential applications in disease diagnosis and precision gene-editing.
A new AI-powered tool, scGen, accurately models cellular response to perturbations, enabling reliable predictions for different systems. This breakthrough has the potential to revolutionize the understanding and treatment of common human diseases.
Researchers at Helmholtz Zentrum München have developed a novel T-cell therapy that can eliminate hepatitis B viruses from the liver, paving the way for a potential cure. The therapy involves genetically modifying patient-specific T cells to recognize and attack infected liver cells, with promising results in a mouse model.
A new magnetic resonance imaging (MRI) protocol has been developed to identify premature babies with chronic lung disease, allowing for earlier diagnosis and personalized treatment. The study, published in Thorax, reveals increased T2 and decreased T1 relaxation times in MRI data, indicating the presence of Bronchopulmonary Dysplasia.
Researchers reconstructed wheat breeding history through genetic analysis, linking its evolution to human migration patterns, geopolitical events, and climate change. This knowledge will help optimize modern wheat varieties for improved yield and adaptability in a growing world population.
Researchers at Helmholtz Munich discover key molecules in the cell nucleus that orchestrate paraspeckles formation, a structure linked to ALS progression. The discovery provides new insights into pluripotency and differentiation processes, potentially leading to breakthroughs in regenerative medicine and therapeutic strategies for ALS.
A team of scientists has discovered that the neuronal transport factor Staufen2 scans and binds to its target transcripts in a more complex manner than previously thought. This finding opens up new approaches to improve our understanding of RNA transport and synaptic plasticity, which is essential for memory and learning.
Researchers developed a mouse model to investigate the role of persistent CD30 signaling in blood cancer development. They found that permanent CD30 activation increases the risk of B-cell lymphoma and can trigger cancer through misdirected cellular processes.
Researchers use PAGA to study developmental processes and understand disease progression. The tool groups cells by type and biological state, revealing transitions between cell types and states, and delivering important results in a clinical context.
Researchers developed a new machine learning model to describe the dynamics of cell development, estimating selection pressure and formation of new cells. The tool simplifies the interpretation of single-cell time series observations, shedding light on vital questions in biology.
Researchers from Helmholtz Munich used optoacoustic imaging with purple bacteria to detect macrophages in tumors, providing insights into their activity and role in cancer development. This breakthrough enables novel non-invasive technologies for diagnosis and treatment.
A study of over 27,000 heart attack patients found an increase in heat-induced heart attacks in recent years, particularly among individuals with diabetes or hyperlipidaemia. Climate change is suspected to be a contributing factor, but the exact mechanism behind these deaths remains unclear.
A study published in Nature Communications reveals that genes in lung cells lose synchronized behavior with age, leading to changes in gene activity and metabolic pathways. The researchers also found alterations in the extracellular matrix surrounding lung cells, affecting protein composition.
Researchers developed a molecular bait to identify proteins involved in the cell's choice of DNA repair pathway, revealing key enzymes for homologous recombination. The discovery opens new possibilities for targeted cancer treatments using PARP inhibitors.
Scientists have identified a key role for protein Akna in regulating neural stem cells via microtubule organization, promoting differentiation and detachment from the niche. This mechanism also plays a crucial role in epithelial-to-mesenchymal transition.
Researchers found that antibiotic resistance genes are transferred between bacteria through viruses and transposons, leading to a fast distribution of resistance genes. This challenges the long-held assumption that only plasmids facilitate gene exchange.
Scientists at Helmholtz Munich found a transcription factor called Tbx3 that plays a pivotal role in maintaining energy and sugar metabolism. Its absence leads to an identity crisis of satiety neurons, resulting in obesity.
Researchers have pinpointed a mechanism that leads to steroid diabetes in patients undergoing long-term cortisone treatment. The findings suggest that the E47 transcription factor plays a key role in the changes in gene expression, particularly in liver cells.
Researchers developed an AI-powered method to correct errors in single-cell RNA sequencing, enabling precise data for every cell. The algorithm, called kBET, quantifies differences between experiments and facilitates comparison of correction results.
Researchers found that the ability of self-renewal declines in old age, especially in certain intermediate stages called transit amplifying progenitors. This leads to a halt in the production of olfactory cells as they tend to remain in the stem cell pool and become less active.
A European Research Council Consolidator grant has been awarded to Dr. Yuval Rinkevich's team at Helmholtz Munich to study the role of fibroblasts in wound healing, with a focus on determining how differences in their populations affect scarring outcomes.
Scientists have mapped the signal determining pancreatic progenitor cell fate, enabling the manufacturing of insulin-producing beta cells from stem cells. The research facilitates combating type 1 diabetes by understanding how extracellular matrix interactions influence cell destiny.
Scientists at Helmholtz Zentrum München have discovered new details about the UHRF1 protein, which regulates gene activity and is produced at elevated levels in cancer cells. The research reveals an unexpected function of the UBL domain in DNA methylation and defines a new role for this domain in regulating gene expression.
Researchers develop a novel combined therapy using icilin, a cold-mimicking molecule, and DMPP, a nicotinic acetylcholine receptor activator, to reduce excess adipose tissue and improve glucose metabolism. The combination is more effective than individual treatments alone.
Scientists at Helmholtz Zentrum München discovered a metabolic network controlled by muscle cell circadian clocks, regulating fat storage and glucose metabolism. The study found that without this internal clock, mice became leaner and had more muscle mass.
IPF is associated with increased extracellular vesicles that relay WNT5A signals to lung cells, leading to scarring and impaired lung function. The study proposes a pharmacological biomarker and therapeutic approach to address this disease.
A large study found that children of mothers with type 1 diabetes have a significantly higher body mass index, waist circumference, and fasting blood glucose level. The researchers suggest that pediatricians should monitor these children for early warning signs of the condition.